D
BioMarin Pharmaceutical Inc. BMRN
$58.58 $0.510.88% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 29.54% 48.62% 17.78% -1.02% 20.88%
Total Depreciation and Amortization -15.89% -6.52% 24.21% -28.18% -3.24%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 47.54% -52.51% 109.70% 10.16% 43.20%
Change in Net Operating Assets -74.74% -8.79% -312.87% 158.37% 36.50%
Cash from Operations 6.24% -6.05% -16.19% 86.49% 152.84%
Capital Expenditure -1.99% 14.14% -5.78% 13.43% 18.30%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 139.31% -111.96% 4,060.19% -97.94% 842.09%
Cash from Investing 55.41% -136.96% 572.88% -117.86% 735.57%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- 100.00% -- --
Issuance of Common Stock -- -- 63.89% -83.70% 308.80%
Repurchase of Common Stock 68.26% -689.96% 16.97% 64.79% 66.38%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 96.95% -17,027.78% 57.14%
Cash from Financing 88.13% -1,456.38% 100.57% -4,057.54% 129.47%
Foreign Exchange rate Adjustments -116.31% -156.55% 186.32% -187.91% 71.25%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 55.73% -60.37% 190.12% -231.78% 2,869.08%